The objective and target of any organization is growth at 45 degree on x & Y axis through best products, best services etc… with latest innovations. Ever since recession has hit the western market the economy and jobs are melting like never before, chapter 11 filing cases are increasing. After all to run an organization revenue has to be generated. As newspapers across North America and the globe continue to flood with stories of economic downturn and businesses fighting to survive, organizations this month are placing a renewed focus on innovation and revenue generation.
Revenue generation through patent lawsuits is the new trend. 35 patent lawsuits have been filed just in 5 plus month time during 2009, wonder how many more are there. Surely first half of 2009 is not good for Google in terms of lawsuits, total 14 lawsuit are been battled.
Lawsuit filing cases of 2009:
- Aloft Media, LLC v. Yahoo! Inc. et al
- Performance Pricing, Inc. v. Google Inc. et al
- Leader Technologies Inc. v. Facebook Inc.
- Actus, LLC v. Bank of America Corp. et al
- Paid Search Engine Tools, LLC v. Google, Inc. et al
- ESN LLC v. Cisco Systems, Inc. et al
- Heartland Recreational Vehicles LLC v. Forest River Inc
- Software Rights Archive, LLC v. Google Inc. et al
- Northeastern University et al v. Google, Inc.,
- Polaris IP, LLC v. Google Inc. et al
- Function Media, L.L.C. v. Google, Inc. et al
- Aloft Media, LLC v. Google, Inc.
- GraphOn Corporation v. Google Inc.
- Google, Inc. v. EMSAT Advanced Geo-Location Technology, LLC et al
- Picsel (Research) Ltd. et al v. Apple Inc.
- Web Tracking Solutions, Inc. et al v. Google, Inc.
- Association For Molecular Pathology et al v. United States Patent and Trademark Office et al
- Cygnus Systems, Inc. v. Microsoft Corporation, et al
- Google Inc. et al v. Egger et al
- Certicom Corporation et al v. Sony Corporation et al
- Klausner Technologies Inc v. Verizon Wireless et al
- Clark v. The Walt Disney Company et al
- HYPERPHRASE TECHNOLOGIES, LLC v. GOOGLE INC.
- BabyAge..com, Inc. v. Leachco, Inc.
- IP Innovation LLC et al v. Google, Inc.
- Elan Microelectronics Corporation v. Apple, Inc.
- Bid for Position, LLC v. AOL, LLC et al
- Soilworks LLC v Midwest Industrial Supply Inc
- Priest et al v Google Inc.
- 21 srl v. Apple Inc. et al
- PACid Group, LLC v. Apple Inc. et al
- Accolade Systems LLC v. Micron Technology Inc et al
- Affinity Labs of Texas, LLC v. Apple, Inc.
- Clear With Computers, LLC v. Bassett Furniture Industries, Inc. et al
- Motorola Inc v. Research In Motion Limited et al
Applied Nanoscience Inc. announced in a press release that it has received formal notification for the issuance of a patent in Singapore for its core technology platform encompassing “Filtering Devices Incorporating Nanoparticles.”
The company has already been issued this similarly broad patent in Taiwan. The patent covers three main ways of associating the nanoparticles with filter media: (1) having pellets of nanoparticles located adjacent to the filter media, (2) coating the filter media with a powder of nanoparticles, and (3) impregnating the nanoparticles into the filter media.
In addition, ANI has received formal communication that the issuance of this same patent is imminent in Russia along with written confirmation that the granting of a patent based upon a divisional application is expected soon in India.
The company has received very positive notification relating to the patent application on their proprietary nanoparticle formulation from the USPTO.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.
Medical Corporation, a medical products company developing and marketing devices to improve cardiac performance through Aortic Flow Therapy, announced today that the USPTO has issued U.S. Patent number 7,331,921 (the ‘921 patent) entitled “Implantable Heart Assist System and Method of Applying Same.” The ‘921 patent which discloses and claims methods and apparatus for intravascular renal (kidney) perfusion is exclusively owned by Orqis and is the Company’s 15th U.S. Patent.
Patent #: US7331921
Title: Implantable heart assist system and method of applying same
Abstract: An extracardiac pumping for supplementing the circulation of blood, including the cardiac output, in a patient without any component thereof being connected to the patient’s heart, and methods of using same. One embodiment of the intravascular extracardiac system comprises a pump with inflow and outflow conduits that are sized and configured to be implantable intravascularly through a non-primary vessel, whereby it may positioned where desired within the patient’s vasculature. The system comprises a subcardiac pump that may be driven directly or electromagnetically from within or without the patient. The pump is configured to be operated continuously or in a pulsatile fashion, synchronous with the patient’s heart, thereby potentially reducing the afterload of the heart. In another embodiment, the system is positioned extracorporeally, with the inflow conduit and outflow conduit applied percutaneously to a non-primary vessel for circulating blood to and from the non-primary vessel or between the non-primary vessel and another blood vessel within the patient’s vasculature.
Assignee: Orqis Medical Corporation
Filed: June 28, 2004
Issued: February 19, 2008
USPTO has awarded Signalife, Inc. a new and important patent entitled “System For, And Method Of, Monitoring Heartbeats Of A Patient”. The patent, which covers 37 claims, will enhance the Company’s ability to develop new proprietary products.